NIA’s intervention testing program at 10 years of age

Age

Volumn 37, Issue 2, 2015, Pages 1-5

  Warner, Huber R ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NONE   (United States)

Author keywords

Aging; Animal models; Gene expression; Life span extension

Indexed keywords

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; BASIC RESEARCH; CONTROLLED STUDY; DISEASE MODEL; DROSOPHILA; GENE EXPRESSION REGULATION; LIFESPAN; MODEL; MOUSE; NATIONAL HEALTH ORGANIZATION; NEMATODE; NONHUMAN; YEAST; ANIMAL; BIOLOGICAL MODEL; DRUG EFFECTS; HUMAN; LONGEVITY; MEDICAL RESEARCH; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PROGRAM DEVELOPMENT; UNITED STATES;

RAPAMYCIN;

ANIMALS; BIOMEDICAL RESEARCH; HUMANS; LONGEVITY; MICE; MODELS, BIOLOGICAL; NATIONAL INSTITUTE ON AGING (U.S.); PROGRAM DEVELOPMENT; RESEARCH DESIGN; SIROLIMUS; UNITED STATES;

EID: 84958170237     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-015-9761-5     Document Type: Article

References (19)

1. Friedman DB, Johnson TE (1988) A mutation in the age-1 gene in Caenorabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics 118:75–86
2. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K et al (2009) Rapamycin fed late in life extends the life span of genetically heterogeneous mice. Nature 460:392–396
3. Harrison DE, Strong R, Allison DB, Ames BN, Astle CM, Artamma H et al (2014) Acarbose, a 17-alpha estradiol and nordihydroguarietic acid extend mouse lifespan preferentially in males. Aging Cell 13:273–282
4. Hasty P, Livi CB, Dodds SG. Jones D, Strong R, Javors M, et al (2013) eRapa restores a normal life span in a FAP mouse model. Cancer Prev Res 7(1)
5. Hayden EC (2014) Pet dogs set to test anti-aging drug. Nature 514:546
6. Kaeberlein M, Kennedy BK (2009) A midlife longevity drug. Nature 460(7253):331–332
7. Leslie M (2013) A putative antiaging drug takes a step from mice to men. Science 342:789
8. Mannick JB, Del Giudice G, Lattanzi M, Valiante NM, Praetgaard J, Huang B et al (2014) mTOR inhibition improves immune function in the elderly. Sci Transl Med 6:268ra 179
9. Miller RA, Harrison DE, Astle CM, Floyd RA, Flurkey K, Hensley KL et al (2007) An aging intervention testing program: study design and interim report. Aging Cell 6:565–575
10. Miller RA, Harrison DE, Astle CM, Bauer JA, Boyd AR, DeCabo R et al (2011) Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci 66:191–201
11. Miller RA, Harrison DE, Astle CM, Fernandez E, Flurkey K, Han M et al (2014) Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction. Aging Cell 13:468–477
12. Powers RW III, Kaeberlein M, Caldwell SD, Kennedy BK, Fields S (2006) Extension of chronological life span in yeast by decreased TOR signaling. Genes Dev 20:174–184
13. Sharp ZD, Strong R (2010) The role of mTOR signaling in controlling mammalian life span: what a fungicide teaches us about longevity. J Gerontol A Biol Sci Med Sci 65:580–589
14. Sierra F (2010) Rapamycin joins the aging fray. J Gerontol A Biol Sci Med Sci 65:577–579
15. Strong R, Miller RA, Astle CM, Floyd RA, Flurkey K, Hensley et al (2008) Nordihydroguarietic acid and aspirin increase lifespan of genetically heterogeneous male mice. Aging Cell 7:641–650
16. Strong R, Miller RA, Astle CM, Bauer JA, de Cabo R, Fernandez E et al (2013) Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium chain triglyceride oil on life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci 68:6–16
17. Warner HR, Ingram D, Miller RA, Nadon NL, Richardson AG (2000) Program for testing biological interventions to promote healthy aging. Mech Ageing Dev 115:199–208
18. Warner HR (2003) Subfield history: use of model organisms in the search for human aging genes. Sci Aging Knowledge Environ (6):re1
19. Wilkinson JE, Burneister L, Brooks SV, Chan C-C, Friedline S, Harrison DE et al (2012) Rapamycin slows aging in mice. Aging Cell 11:675–682